Thomson Reuters (TRI, TRI.TO) announced that it has acquired GeneGo for undisclosed financial terms. Thomson Reuters said that GeneGo will become part of the Healthcare & Science business of Thomson Reuters, effective immediately.
Thomson Reuters said that this acquisition enables it to provide pharmaceutical, biotechnology and academic research communities with solutions that provide better understanding of underlying mechanism of disease and potential therapies.
GeneGo is a provider of biology and disease information, analytics, and decision support solutions for pharmaceutical research and development. GeneGo is headquartered in San Diego and has offices in Moscow and Michigan.
For comments and feedback contact: editorial@rttnews.com
January 30, 2026 15:51 ET The Federal Reserve policy decision was the main event in the final week of January, which saw a heavy flow of economics news. Several data reflecting the trends in the U.S. economy were also released during the week. The interest rate decision from Canada also was in focus. In Europe, economic sentiment data gained attention. The policy decision from Singapore was the highlight in Asia.